Axa
QGENF

Axa’s QIAGEN NV QGENF Stock Holding History

Axa’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-795,624
Closed -$22.3M – 1373
2016
Q4 		$22.3M Sell
795,624
-8,229
-1% -$231K 0.1% 235
2016
Q3 		$22.1M Sell
803,853
-175,365
-18% -$4.81M 0.1% 246
2016
Q2 		$21.4M Sell
979,218
-5,587
-0.6% -$122K 0.1% 256
2016
Q1 		$22M Sell
984,805
-15,636
-2% -$349K 0.1% 246
2015
Q4 		$27.7M Buy
1,000,441
+622,114
+164% +$17.2M 0.12% 220
2015
Q3 		$9.76M Buy
378,327
+104,744
+38% +$2.7M 0.04% 384
2015
Q2 		$6.78M Buy
273,583
+3,164
+1% +$78.4K 0.03% 505
2015
Q1 		$6.82M Sell
270,419
-156,750
-37% -$3.95M 0.03% 496
2014
Q4 		$10M Buy
427,169
+8,732
+2% +$205K 0.04% 386
2014
Q3 		$9.53M Sell
418,437
-16,810
-4% -$383K 0.04% 387
2014
Q2 		$10.6M Buy
435,247
+17,134
+4% +$419K 0.04% 390
2014
Q1 		$8.82M Buy
418,113
+21,411
+5% +$452K 0.04% 410
2013
Q4 		$9.45M Buy
396,702
+4,935
+1% +$117K 0.04% 392
2013
Q3 		$8.38M Buy
391,767
+31,797
+9% +$680K 0.04% 398
2013
Q2 		$7.17M Buy
+359,970
New +$7.17M 0.04% 410

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Axa's QGENF Position: Q1 2017 in Review

Axa sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 795,624 shares — an estimated $22.3M sold.

Axa first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $27.7M in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Axa reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Axa sold 795,624 QIAGEN NV shares in Q1 2017, an estimated $22.3M.
  • Axa first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Axa's QIAGEN NV position peaked at $27.7M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Axa's 13F filing for Q1 2017, filed 11 May 2017.